144 related articles for article (PubMed ID: 10598564)
1. MTA, a novel multitargeted antifolate, from preclinical to phase I and beyond: summary and conclusions.
Calvert H
Semin Oncol; 1999 Apr; 26(2 Suppl 6):105-8. PubMed ID: 10598564
[No Abstract] [Full Text] [Related]
2. Overview of phase I trials of multitargeted antifolate (MTA, LY231514).
Rinaldi DA
Semin Oncol; 1999 Apr; 26(2 Suppl 6):82-8. PubMed ID: 10598560
[TBL] [Abstract][Full Text] [Related]
3. MTA, A Novel Multitargeted Antifolate: from preclinical to phase I and beyond. Proceedings of a meeting. Ixtapa, Mexico, March 13-15, 1998.
Semin Oncol; 1999 Apr; 26(2 Suppl 6):1-110. PubMed ID: 10610578
[No Abstract] [Full Text] [Related]
4. Antifolates: the next millennium.
Allegra CJ
Semin Oncol; 1999 Apr; 26(2 Suppl 6):1-2. PubMed ID: 10598548
[No Abstract] [Full Text] [Related]
5. An overview of folate metabolism: features relevant to the action and toxicities of antifolate anticancer agents.
Calvert H
Semin Oncol; 1999 Apr; 26(2 Suppl 6):3-10. PubMed ID: 10598549
[No Abstract] [Full Text] [Related]
6. Overview of phase II trials of MTA in solid tumors.
O'Dwyer PJ; Nelson K; Thornton DE
Semin Oncol; 1999 Apr; 26(2 Suppl 6):99-104. PubMed ID: 10598563
[TBL] [Abstract][Full Text] [Related]
7. Pemetrexed, an novel multitargeted antifolate: current development and future directions. Proceedings of a meeting. August 17-19, 2000. Colorado Springs, Colorado, USA.
Semin Oncol; 2002 Apr; 29(2 Suppl 5):1-61; quiz 62-9. PubMed ID: 12023785
[No Abstract] [Full Text] [Related]
8. MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma.
Teicher BA; Alvarez E; Liu P; Lu K; Menon K; Dempsey J; Schultz RM
Semin Oncol; 1999 Apr; 26(2 Suppl 6):55-62. PubMed ID: 10598556
[TBL] [Abstract][Full Text] [Related]
9. Pemetrexed: a multitargeted antifolate (ALIMTA, LY-231514).
Jones RJ; Twelves CJ
Expert Rev Anticancer Ther; 2002 Feb; 2(1):13-22. PubMed ID: 12113062
[TBL] [Abstract][Full Text] [Related]
10. Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell lines.
Smith PG; Marshman E; Calvert AH; Newell DR; Curtin NJ
Semin Oncol; 1999 Apr; 26(2 Suppl 6):63-7. PubMed ID: 10598557
[TBL] [Abstract][Full Text] [Related]
11. Pemetrexed (Alimta, MTA, multitargeted antifolate, LY231514) for malignant pleural mesothelioma.
Manegold C
Semin Oncol; 2003 Aug; 30(4 Suppl 10):32-6. PubMed ID: 12917819
[TBL] [Abstract][Full Text] [Related]
12. Biological activity of the multitargeted antifolate, MTA (LY231514), in human cell lines with different resistance mechanisms to antifolate drugs.
Schultz RM; Chen VJ; Bewley JR; Roberts EF; Shih C; Dempsey JA
Semin Oncol; 1999 Apr; 26(2 Suppl 6):68-73. PubMed ID: 10598558
[TBL] [Abstract][Full Text] [Related]
13. Cellular pharmacology of MTA: a correlation of MTA-induced cellular toxicity and in vitro enzyme inhibition with its effect on intracellular folate and nucleoside triphosphate pools in CCRF-CEM cells.
Chen VJ; Bewley JR; Andis SL; Schultz RM; Iversen PW; Shih C; Mendelsohn LG; Seitz DE; Tonkinson JL
Semin Oncol; 1999 Apr; 26(2 Suppl 6):48-54. PubMed ID: 10598555
[TBL] [Abstract][Full Text] [Related]
14. Positioning pemetrexed in the treatment of ovarian cancer.
Ledermann JA; Stebbing J
Eur J Cancer; 2009 May; 45(8):1330-2. PubMed ID: 19264477
[No Abstract] [Full Text] [Related]
15. Preclinical development of Alimta (Pemetrexed, LY231514), a multitargeted antifolate.
Schultz RM
Prog Drug Res; 2005; 63():275-300. PubMed ID: 16265884
[No Abstract] [Full Text] [Related]
16. The role of pemetrexed in the treatment of colorectal cancer.
Hochster H
Semin Oncol; 2002 Dec; 29(6 Suppl 18):54-6. PubMed ID: 12571812
[TBL] [Abstract][Full Text] [Related]
17. Pemetrexed (Alimta): improving outcomes in malignant pleural mesothelioma.
Budde LS; Hanna NH
Expert Rev Anticancer Ther; 2004 Jun; 4(3):361-8. PubMed ID: 15161435
[TBL] [Abstract][Full Text] [Related]
18. Pemetrexed in bladder, head and neck, and cervical cancers.
Paz-Ares L; Ciruelos E; García-Carbonero R; Castellano D; Lopez-Martín A; Cortés-Funes H
Semin Oncol; 2002 Dec; 29(6 Suppl 18):69-75. PubMed ID: 12571815
[TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthase inhibitors in colorectal cancer.
Cassidy J
Semin Oncol; 2000 Oct; 27(5 Suppl 10):83-7. PubMed ID: 11049037
[No Abstract] [Full Text] [Related]
20. [LY231514. A multitargeted antifolate (MTA)].
Lansiaux A; Degardin M; Bailly C
Bull Cancer; 1999 Sep; 86(9):727-31. PubMed ID: 10519965
[No Abstract] [Full Text] [Related]
[Next] [New Search]
